XENE 39.34 (+1.26%)
CA98420N1050BiotechnologyBiotechnology

Xenon Pharmaceuticals (XENE) Stock Highlights

39.34 | +1.26%
2024-11-21 02:14:36
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Statistics

Range Today
38.29 39.45
Volume Today 368.16K
Range 1 Year
28.2 50.99
Volume 1 Year 109.9M
Range 3 Year
23.26 50.99
Volume 3 Year 322.07M
Range 10 Year
2.1 50.99
Volume 10 Year 647.42M

Highlights

Market Capitalization 3.47B (mid)
Floating Shares 69.99M
Current Price 39.34
Price To Earnings -16.93
Price To Book 4.03
Earnings Per Share -2.69
Payout Ratio 0%

Performance

Latest +1.26%
1 Month -11.5%
3 Months -0.96%
6 Months -1.03%
1 Year +33.54%
3 Years +36.17%
5 Years +318.07%
10 Years +189.05%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.